Provided by Tiger Trade Technology Pte. Ltd.

Adaptive Biotechnologies Corp

26.49
+0.40001.53%
Post-market: 26.33-0.1600-0.60%19:30 EDT
Volume:1.53M
Turnover:40.27M
Market Cap:4.23B
PE:-64.41
High:26.85
Open:26.11
Low:25.97
Close:26.09
52wk High:30.74
52wk Low:12.00
Shares:159.76M
Float Shares:125.00M
Volume Ratio:0.74
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4113
EPS(LYR):-0.3922
ROE:-38.76%
ROA:-4.12%
PB:29.61
PE(LYR):-67.55

Loading ...

Adaptive Biotechnologies - Proceeds to Fund Capped Call and Repurchase up to $25 Mln Common Stock

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies - Proceeds Expected to Repay Orbimed Purchase Agreement

THOMSON REUTERS
·
Jun 16

Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering

GlobeNewswire
·
Jun 16

Adaptive Biotechnologies (ADPT) Stock After clonoSEQ Presentations At ASCO And EHA Is 12.6% Undervalued

Simply Wall St.
·
Jun 13

Is Adaptive Biotechnologies (ADPT) Turning clonoSEQ’s MRD Momentum Into a Durable Competitive Moat?

Simply Wall St.
·
Jun 10

Adaptive Biotechnologies shareholders re-elect Hershberg, Owen to board

Reuters
·
Jun 10

Adaptive Biotechnologies Chief People Officer Francis Lo disposes of 39,741 common shares for $695,772.09

Reuters
·
Jun 09

Adaptive Biotechnologies Chief Commercial Officer Susan Bobulsky sells 11,000 shares for $198,000

Reuters
·
Jun 09

Does ADPT’s clonoSEQ Spotlight at ASCO and EHA Reveal a Durable MRD Moat in Oncology?

Simply Wall St.
·
Jun 01

Adaptive Biotech says clonoSEQ MRD test features in 33 ASCO, EHA presentations

Reuters
·
May 29

Adaptive Biotechnologies Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Morgan Stanley Lowers Price Target on Adaptive Biotechnologies to $18 From $21, Keeps Equalweight Rating

MT Newswires Live
·
May 12

A Look At Adaptive Biotechnologies (ADPT) Valuation After Strong Q1 MRD Growth And Raised Full Year Guidance

Simply Wall St.
·
May 10

Stock Track | Adaptive Biotechnologies Soars 8.85% in Pre-market on Strong Q1 Earnings Beat and Analyst Support

Stock Track
·
May 06

Adaptive Biotechnologies Price Target Maintained With a $22.00/Share by BTIG

Dow Jones
·
May 06

J.P. Morgan Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)

TIPRANKS
·
May 06

Stock Track | Adaptive Biotechnologies Soars 5.30% in Night Session on Strong Q1 Earnings Beat

Stock Track
·
May 06

Adaptive Biotechnologies Q1 revenue beats estimates on MRD growth

Reuters
·
May 06

Stock Track | Adaptive Biotechnologies Soars 16.11% After-Hours on Strong Q1 Earnings Beat

Stock Track
·
May 06

Adaptive Biotechnologies Q1 EPS $(0.13) Beats $(0.17) Estimate, Sales $70.874M Beat $60.850M Estimate

Benzinga Earnings
·
May 06